Weekly Rounds with Infection Control Today: Beware Stealth Omicron, How Long is Long COVID?, How IPs Help Patients
Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending January 28.
Here are 5 highlights from ICT®’s wide-ranging coverage of the infection prevention and control world. Everything from interviews with known opinion leaders, to the news that infection preventionists and other health care professionals can use on their jobs.
‘Stealth Omicron’ Starting to Get Noticed, Setting Off Some Alarms
Initial data suggest that it appears to be more infectious than even the highly infectious original Omicron variant.
Long COVID Symptoms Last for a Year for Some Patients
This frequency of symptoms 1 year after recovering from severe COVID-19 disease is concerning, as much is still unknown about “long COVID.”
Those Who Believe in Herd Immunity Cannot Do the Math
COVID-19 mutations are evading our immunity and at the same time our immunity is waning. Herd immunity to disease and the eradication of SARS-CoV-2 is no longer possible.
Despite Little Interaction With Patients, IPs Play Huge Role in Keeping Them Safe
The ability to be an excellent infection preventionist requires lifelong learning and taking the initiative to grow professionally.
Infection Preventionist Called on to Rescue Nursing Homes Hit by Omicron
Linda Spaulding, a member of ICT®’s Editorial Advisory Board, and a consultant, plans to fly out to Hawaii later this week to advise her LTCF clients in that state about how best to get through the current surge.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
